GLEN Share Price Today - Glen Industries on NSE/BSE

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,786.40	#1 4,28,617.20	37.09	#1 58,220.10	6.38	#1 11,565	25.80	45.08
Divis Laboratories	6,638.50	1,76,231.32	69.85	10,560.00	8.73	2,520	13.44	50.39
Torrent Pharmaceuticals	4,463.70	1,51,071.89	70.80	13,886.20	20.34	2,138	-26.91	55.63
Cipla	1,377.00	1,11,231.40	28.80	29,044.60	2.24	3,870	-55.32	51.44
Zydus Life Science	1,098.30	1,10,514.68	21.72	26,719.70	13.65	5,242	7.82	70.28
Dr Reddys Laboratories	1,271.70	1,06,141.55	25.47	33,593.30	-0.44	3,998	-86.05	44.45
Lupin	2,247.20	1,02,706.75	#1 19.32	27,487.50	19.98	5,345	#1 87.72	43.65
Mankind Pharma	2,376.20	98,090.74	50.95	14,277.60	12.03	1,750	31.75	51.33
Aurobindo Pharma	1,453.60	84,425.32	23.98	33,384.70	3.21	3,376	1.99	51.56
Laurus Labs	1,385.70	74,807.93	86.44	6,812.90	#1 21.03	884	21.18	61.02

Annual Financials	2022	2023	2024	2025	2026	TTM
Revenue	97	120	145	171	203	0
Expenses	83	103	120	130	166	0
EBITDA	14	17	25	41	37	0
Operating Profit %	12 %	14 %	17 %	24 %	18 %	0 %
Depreciation	5	6	6	7	8	0
Interest	4	6	7	9	9	0
Profit Before Tax	5	3	11	24	22	0
Tax	1	1	3	6	5	0
Net Profit	4	2	9	18	17	0
EPS in ₹	2.09	0.85	82.42	10.37	6.86	0.00

Balance Sheet	2022	2023	2024	2025	2026
Total Assets	116	137	161	214	291
Fixed Assets	55	73	81	108	120
Current Assets	58	62	78	104	169
Capital Work in Progress	1	0	0	1	12
Investments	0	0	0	0	78
Other Assets	60	64	80	106	0
Total Equity & Liabilities	116	137	161	214	291
Current Liabilities	53	60	75	100	122
Non Current Liabilities	41	41	40	56	30
Total Equity	23	36	46	59	140
Reserve & Surplus	17	31	40	41	107
Share Capital	6	6	6	18	32

Cash Flow	2022	2023	2024	2025
Net Cash Flow	-2	0	-1	1
Investing Activities	-22	-15	-13	-35
Operating Activities	-14	11	14	6
Financing Activities	34	4	-2	30

% Holding	Dec 2024	Jun 2025	Jul 2025	Sept 2025	Mar 2026
Promoter	100.00 %	73.00 %	73.00 %	73.00 %	73.31 %
FIIs	0.00 %	1.83 %	1.83 %	0.22 %	0.00 %
DIIs	0.00 %	9.93 %	9.93 %	9.06 %	6.64 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	0.00 %	11.95 %	11.95 %	12.31 %	15.47 %
Others	0.00 %	3.29 %	3.29 %	5.41 %	4.57 %
No of Share Holders	7	1,267	7	1,196	1,118

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
22 Sept 2025	Annual General Meeting	NA	22 Sept 2025	105.10	99.30
04 Nov 2025	Quarterly Result Announcement	NA	04 Nov 2025	78.26	79.00
27 May 2026	Quarterly Result Announcement	NA	27 May 2026	70.15	73.35

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Glen Industries

Company News

Peer Comparison Compare Peers on Screener

Yearly Financial Results

Balance Sheet

Cash Flow

Share Holding

Corporate Action

Announcements

Technical Indicators